About Centro Oncológico de Panamá
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Clinical Trials at Centro Oncológico de Panamá
During the past decade, Centro Oncológico de Panamá conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
2015-06-23
2021-08-31
Completed
902
Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer
2015-07-28
2019-01-15
Completed
152
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer
2018-12-19
2022-10-12
Completed
160
A Study of Tiragolumab Plus Atezolizumab and Atezolizumab Monotherapy in Participants With Metastatic and/or Recurrent PD-L1-Positive Cervical Cancer
2020-06-30
2023-07-15
Active, not recruiting
172
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Centro Oncológico de Panamá
According to Clinical.Site data, the most researched conditions in "Centro Oncológico de Panamá" are
"Cervical Cancer" (2 trials), "HER2-Positive Early Breast Cancer" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Centro Oncológico de Panamá" in a lesser frequency.
Clinical Trials Intervention Types at Centro Oncológico de Panamá
Most popular intervention types in "Centro Oncológico de Panamá" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials) and "Nab-Paclitaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centro Oncológico de Panamá
The vast majority of trials in "Centro Oncológico de Panamá" are
2 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Centro Oncológico de Panamá
Currently, there are NaN active trials in "Centro Oncológico de Panamá".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Centro Oncológico de Panamá,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centro Oncológico de Panamá, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".